Document is current
Any future updates will be listed below
-
Authors
Morieri, Mario Luca
Longato, Enrico
Sciannameo, Veronica
Donatiello, Emily
Berchialla, Paola
Avogaro, Angelo
Consoli, Agostino
Fadini, Gian Paolo
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 18 September 2025
First Online: 17 October 2025
Declarations
:
: MLM has received lecture or consultancy fee from Amarin, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Guidotti, Merck Sharp & Dohme, Novartis, Novo Nordisk, Sanofi and Servier. ED is an employee of Novo Nordisk Italia SpA. AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda. AC received research grants and/or lecture and/or advisory board and/or consultancy fees from AstraZeneca, Boehringer Ingelheim, Sanofi, Novo Nordisk, Lilly, Abbot and Bayer. MR received speaker fees from Lilly. GPF received grants, honoraria or lecture fees from AstraZeneca, Boehringer, Lilly, Guidotti, Mundipharma, Novartis, Novo Nordisk, Servier, Sanofi. EL, VS and PB have nothing to disclose.
: The DARWIN-T2D, SUSTAIN-6, and LEADER studies were approved by competent ethical committees.
